Vital Signsby BridgeheadAll voices

01  Voice · Academic · Respiratory (asthma/COPD)

Shervin Assassi: no photograph is held, so the academic plate is shown instead.
Academic

Shervin Assassi

Director of rheumatology, McGovern Medical School

Press coverage by month · bar height shows relative volume
Dec 2025Jan 2026FebMarAprMayJuneJulyAugSeptOctNovto date
1

Quoted in the press, across 1 topic since 22 Dec 2025

02  Quoted on · 1 of 29 topics

Open the topic

Shervin Assassi: key facts

Kind of voice
Academic
Role
Director of rheumatology, McGovern Medical School
Press coverage
Quoted in the press
Most recently quoted
22 Dec 2025

04  On the record · press

What Shervin Assassi has said

By outlet · bar length shows relative volume
  • fiercepharma.com

Where Shervin Assassi has been quoted

  1. BI's Jascayd quickly expands lung disease reach with new FDA nodfiercepharma.com · 22 Dec 2025

How we found the articles that name Shervin Assassi: we searched news for these terms.

  • asthma
  • COPD
  • respiratory disease
  • lung cancer screening
  • pulmonary

Also searched with “asthma” in each of 8 national papers, and in the Guardian by editor tag, and in trade press by category. Every term for Respiratory (asthma/COPD)

Verbatim

“debilitating and irreversible impact on lung function”
Director of rheumatology, McGovern Medical School · Respiratory (asthma/COPD) · fiercepharma.com · 22 Dec 2025 · Read the article

Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 13 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.